Physician profile
Thomas B Charles
NPI 1629012042
$6,627.12
in general payments reported to CMS, 2019-2025
22 companies · $38.77 in 2025
The $38.77 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $141 · 2021: $2,333 · 2022: $809 · 2023: $571 · 2024: $2,271 · 2025: $38.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $780.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $2,100.00 | 2024 | |
| Corelink, LLC | $1,340.33 | 2021 | |
| W. L. Gore & Associates, INC. | $1,209.20 | 2019-2024 | C3 Delivery System |
| Cvrx, INC. | $649.30 | 2021-2023 | Barostim Neo System |
| Alafair Biosciences, INC. | $216.19 | 2022-2023 | Versawrap |
| 4web, INC. | $181.40 | 2023 | Spine Truss System |
| Medtronic USA, INC. | $126.88 | 2019 | |
| Medtronic, INC. | $126.15 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Mazor X System |
| Kerecis Limited | $123.34 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Veryan Medical Incorporated | $119.31 | 2022 | |
| Organogenesis INC. | $95.04 | 2021 | |
| Ossur Americas, INC. | $76.39 | 2024-2025 | |
| Ethicon US, LLC | $39.45 | 2022 | |
| Covidien LP | $37.22 | 2020 | |
| Davol INC. | $36.67 | 2023 | Phasix Mesh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36.01 | 2019 | |
| Angiodynamics, INC. | $24.36 | 2023 | Angiovac |
| Inari Medical, INC. | $21.85 | 2021 | |
| Kci USA, INC. | $18.24 | 2023 | Activ.A.C., Prevena |
| Smith+Nephew, INC. | $17.44 | 2019 | |
| Lemaitre Vascular, INC. | $17.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.